Method: Shotgun metagenomic sequencing (CLIA 21D2062464); not cleared or approved by the FDA. Results reflect relative microbial abundance for wellness education purposes. Not intended to diagnose or treat disease and not a substitute for clinical consultation. Microbial associations are based on emerging scientific research and may change over time.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Clostridioides difficile testing
- C. diff pathogen monitoring
- antibiotic-associated gut disruption and spore carriage tracking
What is Clostridioides difficile?
Clostridioides difficile (formerly Clostridium difficile) is a spore-forming bacterium that is the leading cause of antibiotic-associated colitis. It can be asymptomatically carried or cause severe disease when normal gut flora is disrupted by antibiotics. Detected by shotgun metagenomic sequencing.
Why is Clostridioides difficile important?
C. difficile is the most common healthcare-associated gastrointestinal infection. Asymptomatic carriage occurs in a subset of healthy adults. Monitoring for its presence in the context of microbiome health - particularly post-antibiotic - may inform preventive and restorative strategies.
What insights will I get?
Your C. difficile detection result indicates whether this organism is present in your sample. If detected - even asymptomatically - discuss this finding with your care team, particularly in the context of recent antibiotic treatment.





.avif)
.avif)

